Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BendOfa in relapsed or refractory chronic lymphocytic leukemia
2009-017663-42Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Dec 2011
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine and ofatumumab in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by GIMEMA. Primary endpoint: Overall response rate. Started Dec 2011; status: completed.
02
Drugs
bendamustineofatumumab
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2009-017663-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017663-42.